Issue 56, 2024

Synthesis and stability of the [45Ti]Ti–DOTA complex: en route towards aza-macrocyclic 45Ti-based radiopharmaceuticals

Abstract

We report the use of DOTA as a chelator for titanium. The resulting complex is fully characterised and in vitro stability studies reveal its high kinetic inertness against transmetallation and transchelation. The radiolabeling of DOTA with 45Ti, via a guaiacol-based liquid–liquid extraction method, leads to a high radiochemical conversion up to 98%.

Graphical abstract: Synthesis and stability of the [45Ti]Ti–DOTA complex: en route towards aza-macrocyclic 45Ti-based radiopharmaceuticals

Supplementary files

Article information

Article type
Communication
Submitted
16 Apr 2024
Accepted
03 Jun 2024
First published
11 Jun 2024
This article is Open Access
Creative Commons BY license

Chem. Commun., 2024,60, 7148-7151

Synthesis and stability of the [45Ti]Ti–DOTA complex: en route towards aza-macrocyclic 45Ti-based radiopharmaceuticals

T. Roy, E. Pogorilyy, C. P. Kumarananthan, U. A. Kvitastein, M. Foscato, K. W. Törnroos, T. C. H. Adamsen and E. Le Roux, Chem. Commun., 2024, 60, 7148 DOI: 10.1039/D4CC01800A

This article is licensed under a Creative Commons Attribution 3.0 Unported Licence. You can use material from this article in other publications without requesting further permissions from the RSC, provided that the correct acknowledgement is given.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements